Endothelial Permeability, LDL Deposition, and Cardiovascular Risk Factors-a Review
Overview
Authors
Affiliations
Early atherosclerosis features functional and structural changes in the endothelial barrier function that affect the traffic of molecules and solutes between the vessel lumen and the vascular wall. Such changes are mechanistically related to the development of atherosclerosis. Proatherogenic stimuli and cardiovascular risk factors, such as dyslipidaemias, diabetes, obesity, and smoking, all increase endothelial permeability sharing a common signalling denominator: an imbalance in the production/disposal of reactive oxygen species (ROS), broadly termed oxidative stress. Mostly as a consequence of the activation of enzymatic systems leading to ROS overproduction, proatherogenic factors lead to a pro-inflammatory status that translates in changes in gene expression and functional rearrangements, including changes in the transendothelial transport of molecules, leading to the deposition of low-density lipoproteins (LDL) and the subsequent infiltration of circulating leucocytes in the intima. In this review, we focus on such early changes in atherogenesis and on the concept that proatherogenic stimuli and risk factors for cardiovascular disease, by altering the endothelial barrier properties, co-ordinately trigger the accumulation of LDL in the intima and ultimately plaque formation.
Huang K, Pokhrel A, Echesabal-Chen J, Scott J, Bruce T, Jo H Medicina (Kaunas). 2025; 61(2).
PMID: 40005445 PMC: 11857470. DOI: 10.3390/medicina61020329.
Metagenomic estimation of dietary intake from human stool.
Diener C, Holscher H, Filek K, Corbin K, Moissl-Eichinger C, Gibbons S Nat Metab. 2025; .
PMID: 39966520 DOI: 10.1038/s42255-025-01220-1.
Standard Protocols for Characterising Primary and In Vitro-Generated Human Hepatocytes.
Heydari Z, Gramignoli R, Piryaei A, Zahmatkesh E, Pooyan P, Seydi H J Cell Mol Med. 2025; 29(3):e70390.
PMID: 39910642 PMC: 11798750. DOI: 10.1111/jcmm.70390.
Gut microbes modulate the effects of the flavonoid quercetin on atherosclerosis.
Kasahara K, Kerby R, Aquino-Martinez R, Evered A, Cross T, Everhart J NPJ Biofilms Microbiomes. 2025; 11(1):12.
PMID: 39794320 PMC: 11723976. DOI: 10.1038/s41522-024-00626-1.
Apolipoprotein B-containing lipoproteins in atherogenesis.
Boren J, Packard C, Binder C Nat Rev Cardiol. 2025; .
PMID: 39743565 DOI: 10.1038/s41569-024-01111-0.